Conglomerates
Compare Stocks
5 / 10Stock Comparison
RCMT vs HURN vs ICFI vs CRAI vs EXPO
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
Consulting Services
Consulting Services
Consulting Services
RCMT vs HURN vs ICFI vs CRAI vs EXPO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Conglomerates | Consulting Services | Consulting Services | Consulting Services | Consulting Services |
| Market Cap | $204M | $1.94B | $1.26B | $902M | $3.03B |
| Revenue (TTM) | $319M | $1.74B | $1.82B | $771M | $582M |
| Net Income (TTM) | $16M | $104M | $85M | $48M | $106M |
| Gross Margin | 27.2% | 23.3% | 27.2% | 20.3% | 40.1% |
| Operating Margin | 7.9% | 11.3% | 7.9% | 9.8% | 20.6% |
| Forward P/E | 12.4x | 13.6x | 9.9x | 16.9x | 29.9x |
| Total Debt | $26M | $548M | $571M | $127M | $83M |
| Cash & Equiv. | $3M | $25M | $5M | $18M | $222M |
RCMT vs HURN vs ICFI vs CRAI vs EXPO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| RCM Technologies, I… (RCMT) | 100 | 2150.7 | +2050.7% |
| Huron Consulting Gr… (HURN) | 100 | 259.3 | +159.3% |
| ICF International, … (ICFI) | 100 | 106.1 | +6.1% |
| CRA International, … (CRAI) | 100 | 345.6 | +245.6% |
| Exponent, Inc. (EXPO) | 100 | 82.7 | -17.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RCMT vs HURN vs ICFI vs CRAI vs EXPO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RCMT is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 14.7%, EPS growth 28.0%, 3Y rev CAGR 3.9%
- 471.3% 10Y total return vs CRAI's 5.5%
- 14.7% revenue growth vs ICFI's -7.3%
- +38.7% vs CRAI's -23.6%
HURN lags the leaders in this set but could rank higher in a more targeted comparison.
ICFI ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.56, Low D/E 55.6%, current ratio 1.27x
- Lower P/E (9.9x vs 29.9x), PEG 0.86 vs 5.02
- Beta 0.56 vs RCMT's 1.18, lower leverage
CRAI is the clearest fit if your priority is valuation efficiency.
- PEG 0.79 vs EXPO's 5.02
EXPO carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 13 yrs, beta 0.86, yield 2.0%
- Beta 0.86, yield 2.0%, current ratio 2.40x
- 18.2% margin vs ICFI's 4.7%
- 2.0% yield, 13-year raise streak, vs CRAI's 1.5%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.7% revenue growth vs ICFI's -7.3% | |
| Value | Lower P/E (9.9x vs 29.9x), PEG 0.86 vs 5.02 | |
| Quality / Margins | 18.2% margin vs ICFI's 4.7% | |
| Stability / Safety | Beta 0.56 vs RCMT's 1.18, lower leverage | |
| Dividends | 2.0% yield, 13-year raise streak, vs CRAI's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +38.7% vs CRAI's -23.6% | |
| Efficiency (ROA) | 13.7% ROA vs ICFI's 4.1%, ROIC 36.3% vs 7.2% |
RCMT vs HURN vs ICFI vs CRAI vs EXPO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RCMT vs HURN vs ICFI vs CRAI vs EXPO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EXPO leads in 2 of 6 categories
RCMT leads 1 • HURN leads 0 • ICFI leads 0 • CRAI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EXPO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICFI is the larger business by revenue, generating $1.8B annually — 5.7x RCMT's $319M. EXPO is the more profitable business, keeping 18.2% of every revenue dollar as net income compared to ICFI's 4.7%. On growth, HURN holds the edge at +14.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $319M | $1.7B | $1.8B | $771M | $582M |
| EBITDAEarnings before interest/tax | $27M | $231M | $201M | $98M | $125M |
| Net IncomeAfter-tax profit | $16M | $104M | $85M | $48M | $106M |
| Free Cash FlowCash after capex | $17M | $124M | $151M | -$17M | $122M |
| Gross MarginGross profit ÷ Revenue | +27.2% | +23.3% | +27.2% | +20.3% | +40.1% |
| Operating MarginEBIT ÷ Revenue | +7.9% | +11.3% | +7.9% | +9.8% | +20.6% |
| Net MarginNet income ÷ Revenue | +5.1% | +6.0% | +4.7% | +6.2% | +18.2% |
| FCF MarginFCF ÷ Revenue | +5.4% | +7.1% | +8.3% | -2.2% | +21.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.4% | +14.2% | -10.3% | +10.5% | +7.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +116.2% | +0.8% | -22.2% | -35.5% | +6.5% |
Valuation Metrics
Evenly matched — RCMT and ICFI each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 13.4x trailing earnings, RCMT trades at a 55% valuation discount to EXPO's 29.7x P/E. Adjusting for growth (PEG ratio), CRAI offers better value at 0.80x vs EXPO's 4.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $204M | $1.9B | $1.3B | $902M | $3.0B |
| Enterprise ValueMkt cap + debt − cash | $227M | $2.5B | $1.8B | $1.0B | $2.9B |
| Trailing P/EPrice ÷ TTM EPS | 13.40x | 20.54x | 14.06x | 17.15x | 29.67x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.45x | 13.57x | 9.94x | 16.94x | 29.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.22x | 0.80x | 4.98x |
| EV / EBITDAEnterprise value multiple | 8.06x | 10.65x | 8.71x | 10.39x | 22.22x |
| Price / SalesMarket cap ÷ Revenue | 0.64x | 1.14x | 0.67x | 1.20x | 5.20x |
| Price / BookPrice ÷ Book value/share | 4.77x | 4.08x | 1.25x | 4.39x | 8.06x |
| Price / FCFMarket cap ÷ FCF | 11.76x | 10.63x | 10.49x | 48.61x | 24.73x |
Profitability & Efficiency
Evenly matched — RCMT and EXPO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
RCMT delivers a 40.9% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $8 for ICFI. EXPO carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to HURN's 1.04x. On the Piotroski fundamental quality scale (0–9), RCMT scores 8/9 vs CRAI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +40.9% | +21.8% | +8.3% | +23.6% | +25.5% |
| ROA (TTM)Return on assets | +12.5% | +6.8% | +4.1% | +7.6% | +13.7% |
| ROICReturn on invested capital | +26.9% | +15.0% | +7.2% | +20.4% | +36.3% |
| ROCEReturn on capital employed | +31.6% | +18.6% | +9.3% | +26.9% | +19.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 6 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.56x | 1.04x | 0.56x | 0.60x | 0.21x |
| Net DebtTotal debt minus cash | $23M | $524M | $566M | $109M | -$139M |
| Cash & Equiv.Liquid assets | $3M | $25M | $5M | $18M | $222M |
| Total DebtShort + long-term debt | $26M | $548M | $571M | $127M | $83M |
| Interest CoverageEBIT ÷ Interest expense | 9.05x | 7.70x | 6.75x | 14.51x | — |
Total Returns (Dividends Reinvested)
RCMT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RCMT five years ago would be worth $83,295 today (with dividends reinvested), compared to $7,203 for EXPO. Over the past 12 months, RCMT leads with a +38.7% total return vs CRAI's -23.6%. The 3-year compound annual growth rate (CAGR) favors RCMT at 33.1% vs ICFI's -14.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +45.1% | -29.9% | -18.2% | -30.1% | -12.0% |
| 1-Year ReturnPast 12 months | +38.7% | -21.2% | -19.8% | -23.6% | -18.9% |
| 3-Year ReturnCumulative with dividends | +136.0% | +56.2% | -36.5% | +54.6% | -26.7% |
| 5-Year ReturnCumulative with dividends | +732.9% | +112.1% | -21.6% | +78.9% | -28.0% |
| 10-Year ReturnCumulative with dividends | +471.3% | +108.5% | +88.1% | +552.4% | +178.1% |
| CAGR (3Y)Annualised 3-year return | +33.1% | +16.0% | -14.0% | +15.6% | -9.8% |
Risk & Volatility
Evenly matched — RCMT and ICFI each lead in 1 of 2 comparable metrics.
Risk & Volatility
ICFI is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than RCMT's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RCMT currently trades 88.7% from its 52-week high vs CRAI's 61.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.18x | 0.68x | 0.56x | 0.72x | 0.86x |
| 52-Week HighHighest price in past year | $32.50 | $186.78 | $101.71 | $227.29 | $81.95 |
| 52-Week LowLowest price in past year | $17.26 | $112.45 | $64.52 | $134.47 | $60.73 |
| % of 52W HighCurrent price vs 52-week peak | +88.7% | +64.2% | +68.4% | +61.4% | +74.9% |
| RSI (14)Momentum oscillator 0–100 | 50.5 | 44.7 | 62.1 | 29.9 | 36.0 |
| Avg Volume (50D)Average daily shares traded | 67K | 235K | 360K | 186K | 451K |
Analyst Outlook
EXPO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RCMT as "Buy", HURN as "Buy", ICFI as "Buy", CRAI as "Buy", EXPO as "Buy". Consensus price targets imply 66.7% upside for HURN (target: $200) vs 38.4% for EXPO (target: $85). For income investors, EXPO offers the higher dividend yield at 1.96% vs ICFI's 0.81%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $200.00 | $102.50 | $194.00 | $85.00 |
| # AnalystsCovering analysts | 3 | 9 | 13 | 1 | 8 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.8% | +1.5% | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 8 | 9 | 13 |
| Dividend / ShareAnnual DPS | — | — | $0.56 | $2.06 | $1.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.6% | +8.6% | +4.4% | +5.2% | +3.2% |
EXPO leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). RCMT leads in 1 (Total Returns). 3 tied.
RCMT vs HURN vs ICFI vs CRAI vs EXPO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RCMT or HURN or ICFI or CRAI or EXPO a better buy right now?
For growth investors, RCM Technologies, Inc.
(RCMT) is the stronger pick with 14. 7% revenue growth year-over-year, versus -7. 3% for ICF International, Inc. (ICFI). RCM Technologies, Inc. (RCMT) offers the better valuation at 13. 4x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate RCM Technologies, Inc. (RCMT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RCMT or HURN or ICFI or CRAI or EXPO?
On trailing P/E, RCM Technologies, Inc.
(RCMT) is the cheapest at 13. 4x versus Exponent, Inc. at 29. 7x. On forward P/E, ICF International, Inc. is actually cheaper at 9. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CRA International, Inc. wins at 0. 79x versus Exponent, Inc. 's 5. 02x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — RCMT or HURN or ICFI or CRAI or EXPO?
Over the past 5 years, RCM Technologies, Inc.
(RCMT) delivered a total return of +732. 9%, compared to -28. 0% for Exponent, Inc. (EXPO). Over 10 years, the gap is even starker: CRAI returned +552. 4% versus ICFI's +88. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RCMT or HURN or ICFI or CRAI or EXPO?
By beta (market sensitivity over 5 years), ICF International, Inc.
(ICFI) is the lower-risk stock at 0. 56β versus RCM Technologies, Inc. 's 1. 18β — meaning RCMT is approximately 111% more volatile than ICFI relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 104% for Huron Consulting Group Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RCMT or HURN or ICFI or CRAI or EXPO?
By revenue growth (latest reported year), RCM Technologies, Inc.
(RCMT) is pulling ahead at 14. 7% versus -7. 3% for ICF International, Inc. (ICFI). On earnings-per-share growth, the picture is similar: RCM Technologies, Inc. grew EPS 28. 0% year-over-year, compared to -14. 9% for ICF International, Inc.. Over a 3-year CAGR, HURN leads at 14. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RCMT or HURN or ICFI or CRAI or EXPO?
Exponent, Inc.
(EXPO) is the more profitable company, earning 18. 2% net margin versus 4. 9% for ICF International, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 7. 9% for RCMT. At the gross margin level — before operating expenses — ICFI leads at 34. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RCMT or HURN or ICFI or CRAI or EXPO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CRA International, Inc. (CRAI) is the more undervalued stock at a PEG of 0. 79x versus Exponent, Inc. 's 5. 02x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ICF International, Inc. (ICFI) trades at 9. 9x forward P/E versus 29. 9x for Exponent, Inc. — 19. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HURN: 66. 7% to $200. 00.
08Which pays a better dividend — RCMT or HURN or ICFI or CRAI or EXPO?
In this comparison, EXPO (2.
0% yield), CRAI (1. 5% yield), ICFI (0. 8% yield) pay a dividend. RCMT, HURN do not pay a meaningful dividend and should not be held primarily for income.
09Is RCMT or HURN or ICFI or CRAI or EXPO better for a retirement portfolio?
For long-horizon retirement investors, CRA International, Inc.
(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), 1. 5% yield, +552. 4% 10Y return). Both have compounded well over 10 years (CRAI: +552. 4%, RCMT: +471. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RCMT and HURN and ICFI and CRAI and EXPO?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RCMT is a small-cap deep-value stock; HURN is a small-cap quality compounder stock; ICFI is a small-cap deep-value stock; CRAI is a small-cap deep-value stock; EXPO is a small-cap quality compounder stock. ICFI, CRAI, EXPO pay a dividend while RCMT, HURN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.